Sarepta Therapeutics, Inc. (SRPT)

NMS – Real Time Price. Currency in USD

18.35

+0.13 (0.71%)

Market open: Aug 12, 2026, 1:46 PM EDT

18.33

+0.11 (0.61%)

Previous after-hours: Aug 11, 2026, 7:45 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

2.20B

1.90B

1.24B

933M

Cost of goods sold

-884M

-357M

-195M

-182M

Gross Profit

1.31B

1.55B

1.05B

751M

Operating expenses (excl. COGS)

-1.97B

-1.33B

-1.32B

-1.28B

Operating Income

-658M

218M

-268M

-530M

Non-operating income, total

-44M

43M

-252M

-160M

Pretax income

-702M

261M

-520M

-690M

Equity in earnings

Taxes

-11M

-26M

-16M

-14M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-713M

235M

-536M

-703M

Discontinued operations

Net income

-713M

235M

-536M

-703M

Dilution adjustment

17M

Preferred dividends

Sarepta Therapeutics, Inc. (SRPT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Sarepta Therapeutics, Inc. (SRPT)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Sarepta Therapeutics, Inc. (SRPT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Sarepta Therapeutics, Inc. (SRPT)

Income Statement (Annual)

Income Statement (Annual)